Neuro-ophthalmological and neurological diseases and conditions affect approximately 15% of the world population.

Current diagnostic procedures for these conditions rely on subjective assessments and manual procedures, making accurate diagnosis difficult.

At the same time monitoring and treatment procedures for these conditions can be costly and time-consuming, requiring frequent patient visits at the care center.There are millions of underdiagnosed and undertreated patients.Eyecuracy's solution is a hybrid healthcare platform for diagnostics, monitoring, and treatment of neurological and neuro-ophthalmological disorders.

It features a user-friendly, simple, and inexpensive hardware device (cameras), smart cloud service, and proprietary, patent pending powerful AI algorithms.Eyecuracy's platform provides convenient and cost-effective patient care by allowing in-office diagnosis and home monitoring and therapy.

It addresses challenges of ineffective, subjective diagnostics, monitoring, and treatment methods and low adherence by offering objective measurements, remote monitoring, and personalized treatment options.Eyecuracy advantage over the competition lies In the core of its technology - unique accurate AI powered eye tracking algorithm.

Unlike all other commercially available eye tracking solutions, incapable of providing accurate visual axis, due to cornea distortion and uncertainty of cornea shape, Eyecuracy is the first-of-its-kind platform to break this paradigm of infrared cornea reflections, going to the cornea perimeter (the limbus) and using innovative AI data analysis to locate accurately the optical axis, leading to the desired visual axis calculation.Eyecuracy's solution will disrupt and revolutionize the diagnostics, monitoring, and treatment markets of neuro-ophthalmological and neurological diseases and conditions.